Solutions

End-to-end evidence, accelerated by AI

Four interconnected capabilities, delivered by a single team — so your evidence travels seamlessly from study design to launch.

Real-World Evidence Studies

Protocol-to-publication RWE programs across observational, comparative, and external control studies.

  • External control arms
  • Natural history studies
  • Treatment patterns & outcomes

Health Economics & Outcomes Research

Cost, utilization, and value evidence that resonates with payers worldwide.

  • Budget impact models
  • Cost-effectiveness analysis
  • Burden of illness

Market Access & Payer Strategy

Translate evidence into reimbursement wins across global payer archetypes.

  • Value dossiers (AMCP, EU JCA)
  • HTA submission support
  • Payer landscape analytics

Medical Affairs Analytics

Field-ready insights connecting MSL engagement, KOL networks, and scientific narratives.

  • KOL mapping
  • Scientific narrative builder
  • Congress & publication planning

Need something custom?

Our scientific team scopes engagements around your therapeutic questions.

Talk to an expert